A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32)

Manfredi, 2006, Ann Surg, Epidemiology and management of liver metastases from colorectal cancer, 254

Choti, 2002, Ann Surg, Trends in long-term survival following liver resection for hepatic colorectal metastases, 759

Cummings, 2007, Cancer, Survival after hepatic resection in metastatic colorectal cancer: A population-based study, 718

Portier, 2006, J Clin Oncol, Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial, 4976

André, 2004, N Engl J Med, Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer, 2343

Haller, 2011, J Clin Oncol, Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer, 1465

Kuebler, 2007, J Clin Oncol, Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07, 2198

Lembersky, 2006, J Clin Oncol, Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: Results from national surgical adjuvant breast and bowel project protocol C-06, 2059

Network NCC. NCCN clinical practice guideline in oncology: Colon cancer. V.1. In: 2014.

Van, 2010, Ann Oncol, Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment, v93

Arai, 1997, Cancer Chemother Pharmacol, Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer, 526

Rougier, 1992, J Clin Oncol, Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial, 1112

Ensminger, 1983, Semin Oncol, Clinical pharmacology of hepatic arterial chemotherapy, 176

Kemeny, 2002, J Clin Oncol, Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study, 1499

Kemeny, 1999, N Engl J Med, Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer, 2039

Lorenz, 1998, German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann Surg, Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer, 756

Arai Y, Inaba Y, Takeuchi Y. Interventional Techniques for Hepatic Arterial Infusion Chemotherapy. Baltimore: Williams & Wilkins; 1997.

Kurihara, 1999, Psychooncology, Development of quality of life questionnaire in Japan: Quality of life assessment of cancer patients receiving chemotherapy, 355

Schoenfeld, 1982, Biometrics, Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint, 163

Alberts, 2010, J Clin Oncol, Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: A North Central Cancer Treatment Group (NCCTG)/National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66, 853

Kemeny, 2009, Ann Oncol, Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer, 1236

Kemeny, 2011, J Clin Oncol, Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer, 884

Nordlinger, 2008, Lancet, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial, 1007

Primrose JN, Falk S, Finch-Jones M. A randomized clinical trial of chemotherapy compared to chemotherapy in combination with cetuximab in k-RAS wild-type patients with operable metastases from colorectal cancer: The new EPOC study. J Clin Oncol 2013;31. [Abstr 3504].

Karapetis, 2008, N Engl J Med, K-ras mutations and benefit from cetuximab in advanced colorectal cancer, 1757

Van, 2011, J Clin Oncol, Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status, 2011